Acute Myeloid Leukemia, Adult Clinical Trials

8 recruiting

Frequently Asked Questions

Common questions about Acute Myeloid Leukemia, Adult clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 2

Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia

Acute Myeloid Leukemia, AdultNewly Diagnosed
The First Affiliated Hospital of Soochow University172 enrolled1 locationNCT06532552
Recruiting

Observational Study on the Outcome of AML Patients Treated With New Drugs in Real-life (BoxTrial)

Acute Myeloid LeukemiaAcute Myeloid Leukemia, AdultAML, Adult
Gruppo Italiano Malattie EMatologiche dell'Adulto397 enrolled2 locationsNCT06513273
Recruiting
Phase 1Phase 2

A Study to Investigate Treatment of HU and VPA, or 6-MP and VPA in Unfit AML/HR-MDS Patients

Acute Myeloid Leukemia, AdultMyelodysplastic Syndromes, Adult
Haukeland University Hospital48 enrolled1 locationNCT06199557
Recruiting
Phase 2

CLAG-GO for Patients With Persistent, Relapsed or Refractory AML

Acute Myeloid Leukemia, AdultAcute Myeloid Leukemia RecurrentAcute Myeloid Leukemia, Relapsed, Adult
University of Maryland, Baltimore39 enrolled1 locationNCT04050280
Recruiting
Phase 1Phase 2

A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML

Acute Myeloid Leukemia, Adult
Sunshine Lake Pharma Co., Ltd.133 enrolled1 locationNCT05133882
Recruiting
Phase 3

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

Acute Myeloid Leukemia, Adult
Stichting Hemato-Oncologie voor Volwassenen Nederland415 enrolled67 locationsNCT06652438
Recruiting
Phase 1Phase 2

First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients

Myelodysplastic SyndromesAcute Myeloid Leukemia, Adult
Advanced BioDesign36 enrolled3 locationsNCT05601726
Recruiting
Not Applicable

Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML

CardiotoxicityEndothelial DysfunctionAcute Myeloid Leukemia, Adult
Samara State Medical University100 enrolled1 locationNCT05703126